- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03067454
Early Mobilization of Spiral Metacarpal Fractures Compared With Operative Treatment
Early Mobilization of Spiral Metacarpal Fractures Compared With Operative Treatment - a Prospective Randomized Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study is designed as an prospective, randomised controlled trial. The patients are divided into two groups (operative and conservative treatment with early mobilisation). The operative group is treated with internal fixation and 2 weeks in a cast. The conservative group is instructed to do a fist to correct any malrotation and to rehabilitate quickly. By this procedure shortening oft he metacarpalfractures is limited by the function of the deep transverse metacarpal ligament connecting the distal parts of the metacarpalbones II-V. Furthermore the participants in the conservative group are allowed to use their hands without any restrictions. A physiotherapist controls that early mobilisation is carried out.
The participant will be seen for a follow-up at 1, 6 and 12 weeks and 1 year. Radiographs will be performed at 1v and 6v. The finger ranges of motion and pain will be evaluated with every follow-up, DASH score, range of motion, pain and grip-strength will be measured after 12v and 1 year. The investigators will measure return to driving, work and sport.
Complications will be registered continuously for all patients. The overall satisfaction of the patients and the costs for both treatments will be documented as well.
The study population is planned to be 21 patients in each group.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Dalarna
-
Falun, Dalarna, Sweden, 79182
- Falu lasarett, Department of Orthopedics
-
-
Uppsala Län
-
Uppsala, Uppsala Län, Sweden, 75185
- Uppsala University Hospital, Dept. of Handsurgery
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- single spiral fractures of metacarpal bone II-V
- fracture line at least twice the length of the diameter of the bone at the level of the fracture
- at least 1-2mm displacement of the fracture and/or malrotation
- normal hand function before the injury
- fracture less than 10 days old
Exclusion Criteria:
- multiple metacarpal fractures
- open fractures
- incompliance or dementia
- fracture line not twice the length of the diameter of the bone at the level of the fracture
- abnormal hand function before the injury
- fracture more than 10 days old
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: conservative group
Treatment with early mobilisation
|
Conservative treatment with early mobilisation The patient is instructed to do a fist and is not allowed to leave the clinic before. Active mobilisation under control (doctor or physiotherapist) is performed until healing of the fracture is documented. |
|
Other: operative group
Treatment with operation
|
Operation of the fracture.
Usually open reduction and internal fixation with plates and screws or just screws within 2 weeks of injury.
Immobilisation in a cast for two weeks followed by physiotherapy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Grip-strength measured by the JAMAR dynamometer
Time Frame: 1 year
|
Power of the treated hand measured by the JAMAR dynamometer compared with the none-operated hand
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Handfunction rated by the DASH-score
Time Frame: 1 year
|
DASH-score
|
1 year
|
|
Range of motion in the treated hand/fingerray
Time Frame: 1 year
|
Range of motion in the treated hand measured in degrees of active motion with a hand held goniometer (operated fingerray)
|
1 year
|
|
Appearance and severity of complications
Time Frame: 1 year
|
Complications during the different treatments
|
1 year
|
|
Time until the patient can return to work, driving and sport
Time Frame: 1 year
|
Return to work, driving and sport
|
1 year
|
|
The total costs of each treatment
Time Frame: 1 year
|
Costs of each treatment
|
1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Nils Hailer, Professor, Department of Orthopedics, Uppsala University Hospital
- Principal Investigator: Daniel Muder, MD, Dr. med., Department of Orthopedics, Falu lasarett
- Principal Investigator: Grey Giddins, M.B.B.Ch. F.R.C.S. (Orth), Royal United Hospitals Bath NHS Foundation Trust
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FOU 2017-0056
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.